Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga September 15, 2014 at 08:15 AM EDT NPS Pharmaceuticals (NASDAQ: NPSP) fell 10.70% to $29.20 in pre-market trading. The FDA has voted 8-5 in favor of NPS Pharmaceuticals' ... Read More >> Related Stocks: Achison Inc Cree Inc Gilead Sciences Symantec Corp